erlotinib and bexarotene
D-0440
Phase 2 small_molecule completed
Quick answer
erlotinib and bexarotene for Carcinoma, Non-small-cell Lung is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Carcinoma, Non-small-cell Lung
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed